C1-IgG1の構造は,危険パターンの認識が補完体をどのように活性化するかについての洞察を提供します.
Deniz Ugurlar1, Stuart C Howes2, Bart-Jan de Kreuk3
1Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, Netherlands.
まとめ
この研究は,C1複合体が抗体と結合することによって,補完カスケードを開始する方法を明らかにしています. 低温電子顕微鏡では,抗体結合時にC1qアームの凝縮とプロテアスの再配置が示され,免疫反応のトリガーは明らかになった.
科学分野:
- 免疫学
- 構造生物学
- 生物化学
背景:
- 補完カスケードは 生まれつきの免疫と病原体のクリアランスに不可欠です
- C1複合体による補完カスケードの開始は,微生物または宿主細胞の損傷パターンによって引き起こされます.
- C1による補足開始の正確なメカニズムは,まだ完全に理解されていません.
研究 の 目的:
- C1複合体が補足カスケードを開始する構造的メカニズムを解明する.
- C1と抗体,特に免疫グロブリンG1 (IgG1) の相互作用を調査する.
主な方法:
- モノクローン抗体に結合したC1複合体の構造を分析するために,冷凍電子顕微鏡 (cryo-EM) が使用された.
- 観察された相互作用を検証するために,IgG1変異体の機能分析を用いた.
主要な成果:
- C1-IgG1ヘクサマー複合体の異質な構造が観察されました.
- 新しい相互作用を含む,IgG1 Fc- CH2ドメインのC1qの特定の結合部位が特定されました.
- 抗体結合はC1qアームの凝縮,C1r2s2プロテアスの再配置,およびC1q茎の傾きを引き起こした.
- データは,C1sのC1r活性化が単一ストレスのC1複合体内または隣接する複合体間で発生することを示唆しています.
結論:
- C1への抗体結合は,コンフォメーションの変化を誘導し,補完カスケード開始につながる可能性があります.
- この発見は,C1活性化が表面上でどのように起こるかを理解するための構造的基礎を提供します.
- この研究は,古典的な補足経路を通じた先天的な免疫反応の活性化における重要なステップを明らかにしています.
関連する概念動画
Complement System
11.0K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
11.0K
Complementation Tests
6.3K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.3K
Fixed Action Patterns
17.7K
A fixed action pattern (FAP) is a specific, hard-wired sequence of behaviors that occurs in response to an external stimulus, called a sign stimulus. The behavior is “fixed” because it is essentially unchangeable—proceeding similarly across individuals of a species every time it occurs.
17.7K
Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.8K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K


